Characterization of the Temporo-masseteric Nerve Block (TMNB) in Healthy Subjects
Rutgers, The State University of New Jersey · NCT05507164
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–64 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 2
- Target enrollment
- 20
- US sites recruiting
- 1
- Study start
- October 10, 2022
- Record last updated
- December 5, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The proposed pilot study is aimed at preliminary characterization of the TMNB injection in 20 healthy volunteers. Assessment of bite-force distribution and surface electromyographic activity of the temporalis and the masseter muscles, at rest and clench, before and after unilateral TMNB injection, will be the primary outcome measures. Post-injection assessments will be performed at 30 minutes, 2 hours, and 2 weeks after the injection. Participants will be surveyed regarding their experience receiving the TMNB injection (secondary outcomes).
Being studied: Temporomasseteric Nerve Block
Conditions: Occlusion
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18-64 years of age
- All ethnicity
- Male and female sex
- Fluent in written/spoken English
- Never been diagnosed with TMD
- No significant history of orofacial pain
- \<5 headaches/month in the 3 months before enrollment
- No reported use of a nightguard or occlusal splint 'No' to all questions on self-administered questionnaire for TMD screening:
- Pain in jaw or temple on either side of the face in the last 30 days
- Stiffness or pain in jaw upon awakening in the last 30 days
- Any pain increase/reduction in the jaw/temple region during the last 30 days with
- Chewing hard or tough food
- Opening mouth or moving jaw forward or to the side
- Hold teeth together/clenching/grinding/chewing gum
- Using the jaw during activities such as talking, kissing or yawning
Exclusion Criteria
- Traumatic injury/ surgery on face or jaw \< 6 months
- current orthodontic treatment
- pregnant or nursing,
- kidney failure or renal dialysis,
- heart disease or heart failure,
- uncontrolled chronic respiratory disease/ hypertension/ diabetes
- history of
- seizures
- hyperthyroidism
- drug or alcohol abuse
- psychiatric disorder/conditions requiring hospitalization
- chemotherapy/radiation
Recruiting US locations
Rutgers School of Dental Medicine
Newark, NJ 07103
Site contact: Gayathri Subramanian · 973-972-3418 · subramga@sdm.rutgers.edu
Study contacts (from the official record)
- Gayathri D Subramanian · 9739723418 · subramga@sdm.rutgers.edu
Similar studies in New Jersey
All healthy volunteers studies in New Jersey →- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Fair Lawn, NJ + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
Merck Sharp & Dohme LLC
- Location
- Marlton, NJ + 5 other US sites
- Eligibility basics
- Ages 18–64
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Jersey City, NJ + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
Study of Single Doses of HBS-104 in Acutely Sleep-deprived Healthy Participants
Harmony Biosciences Management, Inc.
- Location
- Eatontown, NJ
- Eligibility basics
- Ages 18–55